post-nauka.ru — Contacts, activities, companies, branches, online stores

Information from the site

Information that we collected when analyzing the site

Update date: 22.03.2026

URL site

A unique address of the page on the Internet, on which it can be found and opened in a browser

post-nauka.ru

Site traffic

Metric traffic obtained in the analysis of site visits

Update date: 24.08.2025

Traffic dynamics
Changing the number of visits for the selected period

Geography of the audience
Countries from which visitors of the site come

Sources of traffic
The channels from which visitors come (search, direct call, social networks, etc.)

Visits

The number of site visits for the selected period

541

Pages for a visit

The average number of viewed pages in one visit

1.01

Refusal indicator

The percentage of users who left the site after watching only one page

42.4%

Site positioning
Site positions in various ratings and categories

Top keywords
The most popular keywords for the site

Keyword	VolumeThe number of requests by keyword	Evaluation valueThe approximate cost of traffic by keyword	CPCThe price of a click on an advertising request
постнаука	680.0	-	-
вольтаический	270.0	-	-
смэрть	220.0	-	-
психофизиолог	180.0	-	-

Site headers

Information about HTTP headings received when website request

Update date: 22.03.2026

Status code

HTTP server response, indicating the result of the request

403

Protocol

Data transmission protocol used by the server (for example, HTTP or HTTPS)

http

IP server address

IP address of server, which processed a request

157.90.211.189

The date of the answer

The time when the server formed the answer

Sun, 22 Mar 2026 08:24:07 GMT

Server

Information about server software that processed a request

nginx/1.18.0

The length of the contents

Body body size in bytes

555

Compound

Information about the type of connection (for example, Keep-Alive or Close)

keep-alive

Reply message

Text message accompanying status code

Forbidden

DNS Information

Data obtained in the analysis of the domain zone

Update date: 23.03.2026

URL

The address at which DNS-records were requested

post-nauka.ru

A-record

IPV4 addresses, to which the domain is attached

157.90.211.189

A-record (www)

IPV4 Address Pontodomen www

157.90.211.189

NS-records

Name servers (NAME Servers) serving the domain

ns2.axelname.ru

ns1.axelname.ru

Basic NS (Soa)

The main server of the names indicated in the Soa-record

ns1.axelname.ru

Administrator email (soa)

Email address responsible for the domain specified in the Soa-record

info@axelname.ru

Information Whois

Whois data containing information about the domain and its owner

Update date: 11.02.2026

URL domain

The unique address of the domain on the Internet

post-nauka.ru

Registrar

The company through which the domain is registered

AXELNAME-RU

DNS servers

List of DNS servers related to the domain

ns1.axelname.ru.

ns2.axelname.ru.

The date of creation

Date of registration of domain

01.07.2025

The end of the registration

Date when the domain registration period ends

01.07.2026

Related organizations

Relations map with other organizations

2

ООО "СТП БЛАГОУСТРОЙСТВО"

г Волгоград, ул им. Рихарда Зорге, д 55, кв 4

OKVED: 43.99.4 Работы бетонные и железобетонные

ООО "НК-РТИ-СЕРВИС С"

Респ Татарстан, г Нижнекамск, пр-кт Строителей, д 18

OKVED: 41.20 Строительство жилых и нежилых зданий

Related sites

Relations map with other websites

10

eurasia-neuro.ru

IV Евразийский неврологический конгресс

TIN: 1655499819

TIN: 7708369172

OGRN: 1231600065180

розувастатин.рф

Розувастатин | о препарате, применение, действие, показания и противопоказания

Розувастатин, эффективный представитель семейства статинов, является синтетическим липидоснижающим препаратом, разработанным японской фармацевтической компанией Shionogi и в 2003 году.

rosuvastatin.ru

Розувастатин | о препарате, применение, действие, показания и противопоказания

Розувастатин, эффективный представитель семейства статинов, является синтетическим липидоснижающим препаратом, разработанным японской фармацевтической компанией Shionogi и в 2003 году.